Comparison of the efficacy and tolerability of rosuvastatin with atorvastatin in patients with hypercholesterolaemia: The discovery Penta study

被引：0
|
作者：
Fonseca, FAH
Marotti, M
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] AstraZeneca, Macclesfield, Cheshire, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2005年 / 6卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(05)80425-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：107 / 108
页数：2
相关论文
共 50 条
  • [21] Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)
    Milionis, Haralampos J.
    Rizos, Evangelos
    Kostapanos, Michael
    Filippatos, Theodosios D.
    Gazi, Irene F.
    Ganotakis, Emmanuel S.
    Goudevenos, John
    Mikhailidis, Dimitri P.
    Elisaf, Moses S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (06) : 1123 - 1131
  • [22] Treating to target patients with primary hyperlipidemia: Comparison of the effects of atorvastatin and rosuvastatin (the atoros study)
    Milionis, H.
    Rizos, E.
    Kostapanos, M.
    Filippatos, T.
    Goudevenos, J.
    Mikhailidis, D.
    Elisaf, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 577 - 577
  • [23] Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia
    Stein, EA
    Strutt, K
    Southworth, H
    Diggle, PJ
    Miller, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (11): : 1287 - 1293
  • [24] Comparison of Efficacy of Atorvastatin and Rosuvastatin in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Shuja, Darab
    Mian, Muhammad Umar
    Dhanjal, Manpreet Kaur
    Mengar, Jaina
    Butt, Aqsa A.
    Chaudhari, Sandipkumar S.
    Wei, Calvin R.
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [25] Rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolaemia: Early results of the POLARIS study
    Leiter, LA
    Palmer, M
    Kallend, D
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 113 - 113
  • [26] Rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolaemia: Economic analysis of the POLARIS study
    Miller, PSJ
    Leiter, LA
    Davies, A
    Sosef, F
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 114 - 114
  • [27] EFFICACY OF ROSUVASTATIN VERSUS ATORVASTATIN IN PATIENTS WITH DIABETES: RESULTS OF A SUBGROUP ANALYSIS FROM THE POLARIS STUDY
    Leiter, L. A.
    Sosef, F.
    Ycas, J.
    Melezinkova, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 204 - 204
  • [28] Evaluation of Dose Efficacy of Treatment with Atorvastatin, Rosuvastatin And Simvastatin in Patients with Hyperlipidemia
    Demir, Orhan
    Sevimli, Serdar
    Degirmenci, Husnu
    Duman, Hakan
    Bakirci, Eftal Murat
    Demirelli, Selami
    Hamur, Hikmet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C182 - C182
  • [29] Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients
    Furman, Amy
    Meier, Joy L.
    Malmstrom, Robert A.
    Lopez, Julio R.
    Schaefer, Saul
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (08): : 538 - 544
  • [30] Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial
    Ferdinand, KC
    Clark, LT
    Watson, KE
    Neal, RC
    Brown, CD
    Kong, BW
    Barnes, BO
    Cox, WR
    Zieve, FJ
    Isaacsohn, J
    Ycas, J
    Sager, PT
    Gold, A
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (02): : 229 - 235
12345